Christopher Bowlus, MD

Professor

UC Davis, Gastroenterology and Hepatology

Emailclbowlus@ucdavis.edu

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Christopher Bowlus is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

10 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

5 Finished

SACRAMENTO COLLABORATIVE TO ADVANCE TESTING AND CARE OF HEPATITIS B (SCRATCH)
Bowlus, C.
National Institutes of Health
9/30/14 → 9/29/16
Project: Research project
An Open-Label Study of Ursolkc Acid for Primary Sclerosing Cholangitis
Bowlus, C.
National Institutes of Health
3/24/14 → 1/31/16
Project: Research project
Biologic Basis of Disparity in Liver Cancer Survival Among Asian Americans
Bowlus, C.
National Institutes of Health
9/17/13 → 8/31/16
Project: Research project
Oxidative mutagenesis:Iron, Ascorbic Acid and Genes
Bowlus, C.
National Institutes of Health
9/15/01 → 8/31/03
Project: Research project
CLONING OF THE HEMOCHROMATOSIS LOCUS
Bowlus, C.
National Institutes of Health
8/9/96 → 6/30/01
Project: Research project

8877 Citations
46 h-Index
135 Article
15 Review article
10 Chapter
3 Editorial
More
- 1 Comment/debate
- 1 Short survey

A randomized, placebo-controlled, phase II study of obeticholic acid for primary sclerosing cholangitis
AESOP Study Investigators, Jan 1 2020, (Accepted/In press) In: Journal of Hepatology.
Research output: Contribution to journal › Article › peer-review

Open Access
20 Scopus citations
Bugs in Bile: A Fly in the Ointment?
Shah, S. K. & Bowlus, C. L., Dec 2020, In: Liver Transplantation. 26, 12, p. 1571-1572 2 p.
Research output: Contribution to journal › Editorial › peer-review
Editorial: biochemical responses do not tell the whole story in primary biliary cholangitis
Bowlus, C. L. & Levy, C., Jan 1 2020, In: Alimentary Pharmacology and Therapeutics. 51, 1, p. 177-178 2 p.
Research output: Contribution to journal › Editorial › peer-review

Open Access
Effects of Tumor Necrosis Factor Antagonists in Patients With Primary Sclerosing Cholangitis
International PSC Study Group, Sep 2020, In: Clinical Gastroenterology and Hepatology. 18, 10, p. 2295-2304.e2
Research output: Contribution to journal › Article › peer-review
3 Scopus citations
Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases
International Primary Sclerosing Cholangitis Study Group (IPSCSG), Jan 2020, In: Clinical Gastroenterology and Hepatology. 18, 1, p. 179-187.e6
Research output: Contribution to journal › Article › peer-review

Open Access
20 Scopus citations